Editas Medicine, Inc. (EDIT)

2.07 -0.07 (-3.27%) USD  |  NASDAQ  |  Jan 09, 16:00
2.08 +0.01 (+0.48%) Pre-Market: 09:25
More

Editas Medicine Underperform Recommendations

Underperform Recommendations Chart

View Underperform Recommendations for EDIT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Underperform Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Underperform Recommendations Range, Past 5 Years

View Underperform Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Underperform Recommendations Benchmarks

View Underperform Recommendations Benchmarks
Start Trial
ADMA Biologics, Inc. Upgrade
Arcutis Biotherapeutics, Inc. Upgrade
Daré Bioscience, Inc. Upgrade
Cogent Biosciences, Inc. Upgrade
Janux Therapeutics, Inc. Upgrade